-
1
-
-
66449115267
-
Oxylipins from Dracontium loretense
-
19341262 10.1021/np8006205 1:CAS:528:DC%2BD1MXjvFKlt7c%3D
-
Benavides A, Napolitano A, Bassarello C et al (2009) Oxylipins from Dracontium loretense. J Nat Prod 72(5):813-817
-
(2009)
J Nat Prod
, vol.72
, Issue.5
, pp. 813-817
-
-
Benavides, A.1
Napolitano, A.2
Bassarello, C.3
-
2
-
-
33846526797
-
From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches
-
17294623 10.1177/1352458506071303 1:STN:280:DC%2BD2s%2Fps1KntQ%3D%3D
-
Bifulco M, Laezza C, Malfitano AM (2007) From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches. Mult Scler 13(1):133-134
-
(2007)
Mult Scler
, vol.13
, Issue.1
, pp. 133-134
-
-
Bifulco, M.1
Laezza, C.2
Malfitano, A.M.3
-
3
-
-
63049105150
-
Emerging role of the cannabinoid receptor CB2 in immune regulation: Therapeutic prospects for neuroinflammation
-
10.1017/S1462399409000957
-
Cabral, Griffin-Thomas (2009) Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev Mol Med 20(11):e3
-
(2009)
Expert Rev Mol Med
, vol.20
, Issue.11
, pp. 3
-
-
Cabral1
Griffin-Thomas2
-
4
-
-
59449111015
-
Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells
-
19047095 10.1158/1078-0432.CCR-08-0799 1:CAS:528:DC%2BD1cXhsVegtrbP
-
Cianchi F, Papucci L, Schiavone N et al (2008) Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells. Clin Cancer Res 14(23):7691-7700
-
(2008)
Clin Cancer Res
, vol.14
, Issue.23
, pp. 7691-7700
-
-
Cianchi, F.1
Papucci, L.2
Schiavone, N.3
-
5
-
-
1642543378
-
Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3- carboxamide derivatives as new ligands of cannabinoid receptors
-
15051060 10.1016/j.bmc.2004.01.035 1:CAS:528:DC%2BD2cXisFOgurs%3D
-
Ferrarini PL, Calderone V, Cavallini T et al (2004) Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors. Bioorg Med Chem 12:1921-1933
-
(2004)
Bioorg Med Chem
, vol.12
, pp. 1921-1933
-
-
Ferrarini, P.L.1
Calderone, V.2
Cavallini, T.3
-
6
-
-
32844465920
-
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
-
16472786 10.1016/j.brainres.2005.11.035 1:CAS:528:DC%2BD28XhvVWmtbg%3D
-
Gong JP, Onaivi ES, Ishiguro H et al (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071(1):10-23
-
(2006)
Brain Res
, vol.1071
, Issue.1
, pp. 10-23
-
-
Gong, J.P.1
Onaivi, E.S.2
Ishiguro, H.3
-
7
-
-
84857125719
-
Contributions of endocannabinoid signaling to psychiatric disorders in humans: Genetic and biochemical evidence
-
22123166 10.1016/j.neuroscience.2011.11.020 1:CAS:528: DC%2BC38XisFCktbk%3D 3288440
-
Hillard CJ, Weinlander KM, Stuhr KL (2012) Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience 204:207-229
-
(2012)
Neuroscience
, vol.204
, pp. 207-229
-
-
Hillard, C.J.1
Weinlander, K.M.2
Stuhr, K.L.3
-
8
-
-
18444376760
-
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
-
10.1124/pr.54.2.161 1:CAS:528:DC%2BD38XltVOiuro%3D
-
Howlett AC, Barth F, Bonner TI et al (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmac Rev 54:161-202
-
(2002)
Pharmac Rev
, vol.54
, pp. 161-202
-
-
Howlett, A.C.1
Barth, F.2
Bonner, T.I.3
-
9
-
-
84862826805
-
2-(3-Methoxyphenyl)-5-methyl-1,8-naphthyridin-4(1H)-one (HKL-1) induces G2/M arrest and mitotic catastrophe in human leukemia HL-60 cells
-
22245593 10.1016/j.taap.2011.12.026 1:CAS:528:DC%2BC38XjtFSgsrg%3D
-
Hsu MH, Liu CY, Lin CM et al (2012) 2-(3-Methoxyphenyl)-5-methyl-1,8- naphthyridin-4(1H)-one (HKL-1) induces G2/M arrest and mitotic catastrophe in human leukemia HL-60 cells. Toxicol Appl Pharmacol 259(2):219-226
-
(2012)
Toxicol Appl Pharmacol
, vol.259
, Issue.2
, pp. 219-226
-
-
Hsu, M.H.1
Liu, C.Y.2
Lin, C.M.3
-
10
-
-
21744455710
-
Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation
-
15953683 10.1016/j.neuroscience.2005.02.045 1:CAS:528: DC%2BD2MXlvFynsLg%3D
-
Jackson SJ, Pryce G, Diemel LT et al (2005) Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience 134(1):261-268
-
(2005)
Neuroscience
, vol.134
, Issue.1
, pp. 261-268
-
-
Jackson, S.J.1
Pryce, G.2
Diemel, L.T.3
-
11
-
-
0346350327
-
The cannabinoid system and immune modulation
-
12960289 10.1189/jlb.0303101 1:CAS:528:DC%2BD3sXotlGktLo%3D
-
Klein TW, Newton C, Larsen K et al (2003) The cannabinoid system and immune modulation. J Leukoc Biol 74(4):486-496
-
(2003)
J Leukoc Biol
, vol.74
, Issue.4
, pp. 486-496
-
-
Klein, T.W.1
Newton, C.2
Larsen, K.3
-
12
-
-
70449518017
-
An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis
-
19815071 10.1016/j.nbd.2009.09.020
-
Loría F, Petrosino S, Hernangómez M et al (2010) An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis. Neurobiol Dis 37(1):166-176
-
(2010)
Neurobiol Dis
, vol.37
, Issue.1
, pp. 166-176
-
-
Loría, F.1
Petrosino, S.2
Hernangómez, M.3
-
13
-
-
29244469635
-
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis
-
16239036 10.1016/j.jneuroim.2005.09.005 1:CAS:528:DC%2BD28Xkt1Oq
-
Malfitano AM, Matarese G, Pisanti S et al (2006) Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis. J Neuroimmunol 171(1-2):110-119
-
(2006)
J Neuroimmunol
, vol.171
, Issue.1-2
, pp. 110-119
-
-
Malfitano, A.M.1
Matarese, G.2
Pisanti, S.3
-
14
-
-
56749187087
-
Cannabinoids in the management of spasticity associated with multiple sclerosis
-
19183777 1:CAS:528:DC%2BD1cXhsFektbrJ 2626929
-
Malfitano AM, Proto MC, Bifulco M (2008) Cannabinoids in the management of spasticity associated with multiple sclerosis. Neuropsychiatr Dis Treat 4(5):847-853
-
(2008)
Neuropsychiatr Dis Treat
, vol.4
, Issue.5
, pp. 847-853
-
-
Malfitano, A.M.1
Proto, M.C.2
Bifulco, M.3
-
15
-
-
79951590481
-
Update on the endocannabinoid system as an anticancer target
-
21244344 10.1517/14728222.2011.553606 1:CAS:528:DC%2BC3MXhs1ymu7Y%3D
-
Malfitano AM, Ciaglia E, Gangemi G et al (2011a) Update on the endocannabinoid system as an anticancer target. Expert Opin Ther Targets 15(3):297-308
-
(2011)
Expert Opin Ther Targets
, vol.15
, Issue.3
, pp. 297-308
-
-
Malfitano, A.M.1
Ciaglia, E.2
Gangemi, G.3
-
16
-
-
78650103672
-
Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice
-
20880029 10.1111/j.1476-5381.2010.01047.x 1:CAS:528:DC%2BC3MXksFw%3D 3012408
-
Malfitano AM, Sosa S, Laezza C et al (2011b) Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. Br J Pharmacol 162(1):84-93
-
(2011)
Br J Pharmacol
, vol.162
, Issue.1
, pp. 84-93
-
-
Malfitano, A.M.1
Sosa, S.2
Laezza, C.3
-
17
-
-
84877045028
-
Effects on immune cells of a new 1,8-Naphthyridin-2-One derivative and its analogues as selective CB2 agonists: Implications in multiple sclerosis
-
23658734 10.1371/journal.pone.0062511 1:CAS:528:DC%2BC3sXnsFajsbw%3D 3641032
-
Malfitano AM, Laezza C, D'Alessandro A et al (2013) Effects on immune cells of a new 1,8-Naphthyridin-2-One derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis. PLoS One 8(5):e62511
-
(2013)
PLoS One
, vol.8
, Issue.5
, pp. 62511
-
-
Malfitano, A.M.1
Laezza, C.2
D'Alessandro, A.3
-
18
-
-
33749236407
-
Design, synthesis, and biological evaluation of new 1,8-naphthyridin- 4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists
-
17004710 10.1021/jm0603466 1:CAS:528:DC%2BD28XptVylsrY%3D
-
Manera C, Benetti V, Castelli MP et al (2006) Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists. J Med Chem 49(20):5947-5957
-
(2006)
J Med Chem
, vol.49
, Issue.20
, pp. 5947-5957
-
-
Manera, C.1
Benetti, V.2
Castelli, M.P.3
-
19
-
-
35649019741
-
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists
-
17942307 10.1016/j.bmcl.2007.09.089 1:CAS:528:DC%2BD2sXht1OqsLrK
-
Manera C, Cascio MG, Benetti V et al (2007) New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists. Bioorg Med Chem Lett 17(23):6505-6510
-
(2007)
Bioorg Med Chem Lett
, vol.17
, Issue.23
, pp. 6505-6510
-
-
Manera, C.1
Cascio, M.G.2
Benetti, V.3
-
20
-
-
67549130320
-
Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists
-
19435366 10.1021/jm801563d 1:CAS:528:DC%2BD1MXlslOqsLY%3D
-
Manera C, Saccomanni G, Adinolfi B et al (2009) Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3- carboxamide derivatives as highly selective cannabinoid-2 receptor agonists. J Med Chem 52(12):3644-3651
-
(2009)
J Med Chem
, vol.52
, Issue.12
, pp. 3644-3651
-
-
Manera, C.1
Saccomanni, G.2
Adinolfi, B.3
-
21
-
-
84860341479
-
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold
-
22483967 10.1016/j.ejmech.2012.03.031 1:CAS:528:DC%2BC38XmtlSksrk%3D
-
Manera C, Saccomanni G, Malfitano AM et al (2012) Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold. Eur J Med Chem 52:284-294
-
(2012)
Eur J Med Chem
, vol.52
, pp. 284-294
-
-
Manera, C.1
Saccomanni, G.2
Malfitano, A.M.3
-
22
-
-
26844448746
-
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
-
16086683 10.1111/j.1471-4159.2005.03380.x 1:CAS:528:DC%2BD2MXhtFegu7jM
-
Maresz K, Carrier EJ, Ponomarev ED et al (2005) Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 95(2):437-445
-
(2005)
J Neurochem
, vol.95
, Issue.2
, pp. 437-445
-
-
Maresz, K.1
Carrier, E.J.2
Ponomarev, E.D.3
-
23
-
-
0025325535
-
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
-
2165569 10.1038/346561a0 1:CAS:528:DyaK3cXls1Ghu7w%3D
-
Matsuda LA, Lolait SJ, Brownstein MJ et al (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564
-
(1990)
Nature
, vol.346
, pp. 561-564
-
-
Matsuda, L.A.1
Lolait, S.J.2
Brownstein, M.J.3
-
24
-
-
65449146377
-
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
-
19226257 10.1111/j.1476-5381.2008.00048.x 1:CAS:528:DC%2BD1MXpt1Wlsrk%3D 2697681
-
Pertwee RG (2009) Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 156(3):397-411
-
(2009)
Br J Pharmacol
, vol.156
, Issue.3
, pp. 397-411
-
-
Pertwee, R.G.1
-
25
-
-
0242304878
-
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
-
12876144 10.1093/brain/awg224
-
Pryce G, Ahmed Z, Hankey DJ et al (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 126(Pt 10):2191-2202
-
(2003)
Brain
, vol.126
, Issue.PART 10
, pp. 2191-2202
-
-
Pryce, G.1
Ahmed, Z.2
Hankey, D.J.3
-
26
-
-
59649083643
-
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption
-
19059369 10.1016/j.bone.2008.10.056 1:CAS:528:DC%2BD1MXhvF2qsbk%3D
-
Rossi F, Siniscalco D, Luongo L et al (2009) The endovanilloid/ endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone 44(3):476-484
-
(2009)
Bone
, vol.44
, Issue.3
, pp. 476-484
-
-
Rossi, F.1
Siniscalco, D.2
Luongo, L.3
-
27
-
-
67650088001
-
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon
-
19479993 10.1002/ijc.24483 1:CAS:528:DC%2BD1MXovVersb4%3D
-
Santoro A, Pisanti S, Grimaldi C et al (2009) Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon. Int J Cancer 125(5):996-1003
-
(2009)
Int J Cancer
, vol.125
, Issue.5
, pp. 996-1003
-
-
Santoro, A.1
Pisanti, S.2
Grimaldi, C.3
-
28
-
-
17644396349
-
Immunology of multiple sclerosis
-
15771584 10.1146/annurev.immunol.23.021704.115707 1:CAS:528: DC%2BD2MXktFOju7w%3D
-
Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747
-
(2005)
Annu Rev Immunol
, vol.23
, pp. 683-747
-
-
Sospedra, M.1
Martin, R.2
-
29
-
-
26844504226
-
Identification and functional characterization of brainstem cannabinoid CB2 receptors
-
16224028 10.1126/science.1115740
-
Van Sickle MD, Duncan M, Kingsley PJ et al (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310(5746):329-332
-
(2005)
Science
, vol.310
, Issue.5746
, pp. 329-332
-
-
Van Sickle, M.D.1
Duncan, M.2
Kingsley, P.J.3
-
30
-
-
67649101330
-
Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke
-
19255856 10.1007/s11481-009-9148-4 2855650
-
Zhang M, Martin BR, Adler MW et al (2009) Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke. J Neuroimmune Pharmacol 4(2):249-259
-
(2009)
J Neuroimmune Pharmacol
, vol.4
, Issue.2
, pp. 249-259
-
-
Zhang, M.1
Martin, B.R.2
Adler, M.W.3
|